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1. INTRODUCTION {#mgg31197-sec-0005}
===============

Musculocontractural Ehlers--Danlos Syndrome (mcEDS) is a rare connective tissue disorder, caused by biallelic loss‐of‐function variants in *CHST14* (mcEDS‐*CHST14*) (MIM\#601776) or in *DSE* (mcEDS‐*DSE*) (MIM\#615539), both of which result in defective dermatan sulfate (DS) biosynthesis (Brady, Demirdas, & Fournel‐Gigleux, [2017](#mgg31197-bib-0001){ref-type="ref"}; Malfait, Francomano, & Byers, [2017](#mgg31197-bib-0007){ref-type="ref"}). Hallmarks of mcEDS include altered craniofacial features, multiple congenital contractures (e.g., adducted thumbs, talipes equinovarus), characteristic fine palmar creases, peculiar finger shapes, progressive spinal and foot deformities, large subcutaneous hematomas, and ophthalmological and urogenital involvement (Brady et al., [2017](#mgg31197-bib-0001){ref-type="ref"}). Only five patients with mcEDS‐*DSE* have been described in the literature (Müller, Mizumoto, & Suresh, [2013](#mgg31197-bib-0012){ref-type="ref"}; Schirwani et al., [2019](#mgg31197-bib-0014){ref-type="ref"}; Syx, Van Damme, & Symoens, [2015](#mgg31197-bib-0015){ref-type="ref"}) in contrast to 41 patients with mcEDS‐*CHST14* (Brady et al., [2017](#mgg31197-bib-0001){ref-type="ref"}; Kono, Hasegawa‐Murakami, & Sugiura, [2016](#mgg31197-bib-0005){ref-type="ref"}; Sandal & Kaur, [2018](#mgg31197-bib-0013){ref-type="ref"}). Here, we report detailed clinical, molecular, and glycobiological findings in three additional patients with mcEDS‐*DSE*.

2. CLINICAL REPORT {#mgg31197-sec-0006}
==================

Patient 1, a 19‐year‐old man and average high school student, was born of consanguineous Turkish parents. Pregnancy was complicated by premature rupture of membranes and he was delivered by emergency cesarean section at gestational week 29. At birth, he exhibited cyanosis and bradycardia with Apgar scores of 7 at 1 min and 10 at 5 min. His birth weight was 1,215 g (−1 standard deviation \[*SD*\]), length was 35 cm (−3 *SD*s), and occipitofrontal circumference (OFC) was 26.7 cm (−0.5 *SD*).

In infancy to early childhood, he exhibited large anterior fontanel, brachycephaly, low hairline, wide neck, hypertelorism, blue sclera, short nose with hypoplastic columella, long philtrum, and thin upper lip vermilion. He had bilateral adducted thumbs, arachnodactyly, and rocker bottom feet, but did not exhibit talipes equinovarus. He had umbilical hernia, diastasis recti, bilateral hydronephrosis, and cryptorchidism. He experienced recurrent constipation, which was treated with laxatives. Echocardiography revealed an atrial septal defect and patent ductus arteriosus. He exhibited delayed motor development and mild hypotonia; he sat without support at age 8 months and walked unassisted at 18 months. He underwent surgeries for strabismus and cryptorchidism at 3 and 5 years of age, respectively.

At 8 years of age, brain magnetic resonance imaging showed cortical heterotopia. He was diagnosed with myopia and strabismus, and later diagnosed with unilateral 40 dB high‐frequency sensorineural hearing loss. During his school years, he experienced repeated shoulder luxation and large subcutaneous hematomas at various locations (each antebrachium and the gluteal region) after minor traumas and without the evidence of coagulation defects. He had mild scoliosis and joint hypermobility, and underwent surgery for pes cavus at 11 years of age. His skin was hyperextensible with delayed wound healing. At 15 years of age, he had a self‐limiting hemoptysis with no evidence of tuberculosis.

At 18 years of age, his height was 178 cm (−0.2 *SD*), weight was 77 kg (+0.5 *SD*), and OFC was 58 cm (+2 *SD*s). He had downslanting palpebral fissures, grey sclera, but no hypertelorism. His ears were not rotated or low‐set; however, his right ear showed underfolded helix, lower insertion of the lobule than on the left side, and pits on the posterior conchae. He had dental crowding, and his skin was hyperextensible, with fine palmar (Figure [1b](#mgg31197-fig-0001){ref-type="fig"}) and solar creases, and broadened surgical scars on the right foot (Figure [1d](#mgg31197-fig-0001){ref-type="fig"}). His fingers were long and slender with joint laxity and a swan‐neck deformity, as well as the radial deviation of the bilateral second to fourth fingers (Figure [1a](#mgg31197-fig-0001){ref-type="fig"}). He had bilateral pes cavus (Figure [1e](#mgg31197-fig-0001){ref-type="fig"}), mild pectus excavatum (Figure [1c](#mgg31197-fig-0001){ref-type="fig"}), and lumbar scoliosis. He had no echocardiographic abnormalities, but was diagnosed with high blood pressure and treated with an angiotensin‐converting enzyme inhibitor.

![Clinical photographs of patient 1 at 18 years of age (a−e), patient 2 at 12.5 years of age (f−h), and patient 3 at 21 years of age (i−m)](MGG3-8-e1197-g001){#mgg31197-fig-0001}

Patient 2, a 14‐year‐old girl and average student, was born of consanguineous Indian parents. After an uncomplicated pregnancy, she had been delivered vaginally at term with a birth weight of 2.5 kg; she had normal developmental milestones. She experienced intermittent joint pain and swelling after exercise (left knee and right ankle) and exhibited scoliosis at 11 years of age. She had astigmatism, but normal hearing.

At 12.5 years of age, her height was 141 cm, weight was 27.9 kg, and OFC was 48 cm (all below the third centile). She had hypertelorism, blue sclera, and a broad tall nasal bridge; she had no skin hyperextensibility or apparent scars. Her fingers and toes were long with mild finger webbing (Figure [1f](#mgg31197-fig-0001){ref-type="fig"},h), and crisscrossing palmar and solar creases (Figure [1g](#mgg31197-fig-0001){ref-type="fig"}). Joint laxity was limited to the dorsal subluxation of the metacarpophalangeal joints, especially the thumbs. Her chest was asymmetric with pectus carinatum and she had thoracic kyphoscoliosis. Her bone mineral density, measured by dual‐energy X‐ray absorptiometry, was reduced to 0.659 g/cm^2^ at the lumbar spine (normal range for 20‐year‐old women, 0.8−1.2 g/cm^2^), and 0.513 g/cm^2^ at the femoral neck (normal range for 20‐year‐old women, 0.6−1.0 g/cm^2^). She had no echocardiographic abnormalities or muscle weakness.

Patient 3, a 22‐year‐old man and the older brother of patient 2, was born at term after an uncomplicated pregnancy, with a birth weight of 2.9 kg. He had bilateral talipes equinovarus, which was treated with serial casting and surgical correction at 1 year of age. His early psychomotor development was normal. He experienced right arm fracture after a fall at 4 years of age and right fifth finger fracture at 7 years of age. He developed a large subcutaneous hematoma in his left calf twice, both requiring surgical evacuation. He also had intermittent bruises over his shins. He exhibited scoliosis at 14 years of age, which progressed and required surgical correction at 20 years of age. He had myopia, but normal hearing. He attended a normal school, but did not perform well.

At 21 years of age, his height was 151 cm and weight was 40 kg (both below the third centile). He had small simple ears, mild hypertelorism, blue sclera, a broad tall nasal bridge (Figure [1i](#mgg31197-fig-0001){ref-type="fig"}), and retained primary teeth. Atrophic surgical scars, finger webbing, and abnormal palmar (Figure [1j](#mgg31197-fig-0001){ref-type="fig"},k) and solar creases were present; skin hyperextensibility was absent. He had an asymmetric chest (Figure [1i](#mgg31197-fig-0001){ref-type="fig"}), long fingers and toes (Figure [1l](#mgg31197-fig-0001){ref-type="fig"},m), hallux valgus, and plantar subluxation of the metatarsophalangeal joint of the halluces, as well as prominent calcaneus (Figure [1m](#mgg31197-fig-0001){ref-type="fig"}). He developed multiple joint contractures resulting in reduced ankle dorsiflexion, hip flexion, elbow extension, and wrist dorsiflexion.

3. MOLECULAR INVESTIGATION {#mgg31197-sec-0007}
==========================

Sanger sequencing of *CHST14* and *DSE* was performed for patient 1 based on clinical suspicion of mcEDS. No pathogenic variants were detected in *CHST14*; a homozygous nonsense variant was identified in *DSE* (NM_013352.4, c.960T\>A, p.(Tyr320\*)) (Figure [2a](#mgg31197-fig-0002){ref-type="fig"}). For patient 2, whole exome sequencing was performed (Data [S1](#mgg31197-sup-0005){ref-type="supplementary-material"}; Miyake, Tsurusaki, & Koshimizu, [2016](#mgg31197-bib-0009){ref-type="ref"}) and a homozygous frameshift variant was identified in *DSE* (NM_013352.4, c.996dupT, p.(Val333Cysfs\*4)); patient 3 exhibited homozygosity for this variant, whereas their parents exhibited heterozygosity (Figure [2a](#mgg31197-fig-0002){ref-type="fig"}). None of the identified *DSE* variants were registered in ExAC, Exome Variant Server, or Human Genetic Variant Database.

![Molecular investigation. (a) Pedigree information and intrafamilial segregation of detected variants in *DSE*. (b) cDNA structure of *DSE* and pathogenic variants (mcEDS‐*DSE*). Untranslated regions (UTRs) are shown as orange bars. The first base and each position of exon‐exon junctions in open reading frames (ORFs) are shown in light blue. Pathogenic variants reported in this study are shown in red characters. ex: exon](MGG3-8-e1197-g002){#mgg31197-fig-0002}

4. GLYCOBIOLOGICAL ANALYSIS {#mgg31197-sec-0008}
===========================

Disaccharide compositions of DS and chondroitin sulfate (CS) chains in urine samples from patient 1 and an age‐matched healthy man were analyzed as described previously (Data [S2](#mgg31197-sup-0006){ref-type="supplementary-material"}; Mizumoto, Kosho, & Hatamochi, [2017](#mgg31197-bib-0010){ref-type="ref"}). DS disaccharide was not detected in the urine of patient 1, whereas it was present in the urine of the age‐matched healthy man (Figure [S1](#mgg31197-sup-0001){ref-type="supplementary-material"}; Table [S1A](#mgg31197-sup-0002){ref-type="supplementary-material"}). In contrast, the amount of CS disaccharides in the urine was similar between patient 1 and the age‐matched healthy man (Figure [S1](#mgg31197-sup-0001){ref-type="supplementary-material"}; Table [S1B](#mgg31197-sup-0002){ref-type="supplementary-material"}).

5. DISCUSSION {#mgg31197-sec-0009}
=============

We presented three patients with mcEDS‐*DSE* from two new families. Clinical and molecular features of the five previously reported patients (Müller et al., [2013](#mgg31197-bib-0012){ref-type="ref"}; Schirwani et al., [2019](#mgg31197-bib-0014){ref-type="ref"}; Syx et al., [2015](#mgg31197-bib-0015){ref-type="ref"}), including additional information of the sisters reported by Syx et al. ([2015](#mgg31197-bib-0015){ref-type="ref"}) and the three patients in this series are reviewed in Table [1](#mgg31197-tbl-0001){ref-type="table"}. Truncating variants in *DSE* were identified in the three current patients, whereas previously detected variants were missense in three families and a frameshift variant in one family. Significant reduction or loss of epimerase activity and a marked reduction in DS disaccharides were demonstrated in the patient with p.(Ser268Leu) (Müller et al., [2013](#mgg31197-bib-0012){ref-type="ref"}). A minor fraction of DS was detected as the glycosaminoglycan component of decorin in the patient with p.(Arg267Gly) (Syx et al., [2015](#mgg31197-bib-0015){ref-type="ref"}). The preservation of DS moieties in mcEDS‐*DSE*, in contrast to the complete loss of DS in mcEDS‐*CHST14* (Dündar, Müller, & Zhang, [2009](#mgg31197-bib-0003){ref-type="ref"}; Miyake, Kosho, & Mizumoto, [2010](#mgg31197-bib-0008){ref-type="ref"}), suggested the residual activity of mutant DSE or partially compensating activity of dermatan sulfate epimerase‐like protein (encoded by *DSEL*) (Syx et al., [2015](#mgg31197-bib-0015){ref-type="ref"}). The measurement of the disaccharide compositions of DS and CS chains in a urine sample is a recently established non‐invasive method to screen for mcEDS‐*CHST14* through the assessment of DS biosynthesis (Mizumoto et al., [2017](#mgg31197-bib-0010){ref-type="ref"}). The lack of DS in the urine sample from patient 1 in this study suggests that this test may also be useful for screening of mcEDS‐*DSE*.

###### 

Clinical and molecular features of patients with mcEDS‐*DSE*

  Patient                                                                     1                                                            2                                                                  3                                                               4                                                 5                                                                         6                                                  7                                          8                                    Total (*n* = 8)   mcEDS‐*CHST14* (*n* = 41)
  --------------------------------------------------------------------------- ------------------------------------------------------------ ------------------------------------------------------------------ --------------------------------------------------------------- ------------------------------------------------- ------------------------------------------------------------------------- -------------------------------------------------- ------------------------------------------ ------------------------------------ ----------------- ---------------------------
  Family                                                                      1                                                            2                                                                  3                                                               4                                                 5                                                                         6                                                                                                                                                    
  Publication                                                                 Müller et al. ([2013](#mgg31197-bib-0012){ref-type="ref"})   Syx et al. ([2015](#mgg31197-bib-0015){ref-type="ref"})            Schirwani et al. ([2019](#mgg31197-bib-0014){ref-type="ref"})   This study                                                                                                                                                                                                                                                                       
                                                                              Patient 1                                                    Patient 2                                                          Patient 1                                                       Patient 2                                         Patient 3                                                                                                                                                                                                                      
  Mutation (cDNA)                                                             c.803C\>T/homo                                               c.799A\>G/homo                                                     c.1150_1157del/homo                                             c.1763A\>G/homo                                   c.960T\>A/homo                                                            c.996dupT/homo                                                                                                                                       
  Amino acid change (amino acid)                                              p.Ser268Leu                                                  p.Arg267Gly                                                        p.Pro384Trpfs\*9                                                p.His588Arg                                       p.Tyr320\*                                                                p.Val333Cysfs\*4                                                                                                                                     
  Age at the publication (years)                                              2                                                            48                                                                 39                                                              33                                                2                                                                         19                                                 14                                         22                                                      
  Sex                                                                         M                                                            F                                                                  F                                                               M                                                 M                                                                         M                                                  F                                          M                                    M 5, F 3          M 22, F 19
  Origin                                                                      Indian                                                       Spanish                                                            Portuguese                                                      Pakistani                                         Turkish                                                                   Indian                                                                                                                                               
  Craniofacial                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
  Large fontanel with delayed closure (early childhood)                       Yes                                                          NR                                                                 NR                                                              NR                                                Yes                                                                       Yes                                                NR                                         NR                                   3/3 (100%)        23
  Small mouth/micro‐retrognathia (infancy)                                    NR                                                           Yes                                                                Yes                                                             Yes                                               NR                                                                        NR                                                 NR                                         NR                                   3/3 (100%)         
  Slender face/protruding jaw (from adolescence)                              NR                                                           NR                                                                 NR                                                              Yes[^a^](#mgg31197-note-0003){ref-type="fn"}      NR                                                                        No                                                 No                                         Yes                                  2/4 (50%)         11
  Facial asymmetricity (from adolescence)                                     NR                                                           NR                                                                 NR                                                              No[^a^](#mgg31197-note-0003){ref-type="fn"}       NR                                                                        Yes                                                No                                         No                                   1/4 (25%)         10
  Hypertelorism                                                               Yes                                                          Yes                                                                Yes                                                             NR                                                NR                                                                        Yes                                                Yes                                        Yes                                  6/6 (100%)        35
  Downslanting palpebral fissures                                             Yes                                                          Yes                                                                Yes                                                             Yes                                               Yes                                                                       Yes                                                No                                         Yes                                  7/8 (88%)         34
  Short palpebral fissures                                                    NR                                                           Yes                                                                Yes                                                             No[^a^](#mgg31197-note-0003){ref-type="fn"}       Yes                                                                       Yes                                                No                                         No                                   4/7 (57%)          
  Blue sclera                                                                 Yes                                                          Yes                                                                Yes                                                             NR                                                NR                                                                        Yes                                                Yes                                        Yes                                  6/6 (100%)        25
  Midfacial hypoplasia                                                        NR                                                           Yes                                                                Yes                                                             No[^a^](#mgg31197-note-0003){ref-type="fn"}       NR                                                                        Yes                                                Yes                                        Yes                                  5/6 (83%)          
  Short nose with hypoplastic columella                                       NR                                                           Yes                                                                Yes                                                             No[^a^](#mgg31197-note-0003){ref-type="fn"}       No[^a^](#mgg31197-note-0003){ref-type="fn"}                               No                                                 No                                         No                                   2/7 (29%)         16
  Ear deformity (e.g. low‐set, posterior rotation, prominent)                 Yes                                                          Yes                                                                Yes                                                             Yes                                               Yes                                                                       Yes                                                No                                         Yes                                  7/8 (88%)         33
  Palatal abnormalities (e.g. high, cleft)                                    Yes                                                          NR                                                                 NR                                                              Yes                                               No                                                                        No                                                 Yes                                        NR                                   3/5 (60%)         25
  Long philtrum and/or thin upper lip vermilion                               NR                                                           Yes (thin upper lip vermilion)                                     Yes (both)                                                      No[^a^](#mgg31197-note-0003){ref-type="fn"}       Yes (thin upper lip vermilion)[^a^](#mgg31197-note-0003){ref-type="fn"}   No                                                 No                                         No                                   3/7 (43%)         24
  Crowded teeth                                                               Yes                                                          NR                                                                 NR                                                              Yes                                               NR                                                                        Yes                                                NR                                         NR                                   3/3 (100%)         
  Brachycephaly/flat occiput                                                  Yes                                                          NR                                                                 NR                                                              No[^a^](#mgg31197-note-0003){ref-type="fn"}       Yes                                                                       Yes                                                No                                         No                                   3/6 (50%)          
  Others                                                                                                                                   Hypotonic face with wrinkled and saggy eyelids, cheeks, and neck                                                                   Prominent forehead                                                                                                                                                                                                                                                                
  Skeletal                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
  Congenital multiple contractures[^a^](#mgg31197-note-0003){ref-type="fn"}   Yes                                                          Yes                                                                Yes                                                             Yes                                               Yes                                                                       Yes                                                No                                         Yes                                  7/8 (88%)         41
  Adducted thumbs                                                             Yes (bil)                                                    No                                                                 No                                                              Yes (bil)                                         Yes (bil)                                                                 Yes (bil)                                          No                                         No                                   4/8 (50%)         33
  Talipes equinovarus                                                         Yes (bil)                                                    Yes (bil)                                                          Yes (bil)                                                       Yes (bil)                                         Yes (bil)                                                                 No                                                 No                                         Yes (bil)                            6/8 (75%)         41
  Recurrent/chronic joint dislocations                                        NR                                                           No                                                                 NR                                                              No                                                No                                                                        Yes (shoulder)                                     No                                         No                                   1/6 (17%)         20
  Pectus deformilties                                                         NR                                                           NR                                                                 NR                                                              NR                                                No                                                                        Yes (mild excavatum)                               Yes (excavatum, asymmetric)                Yes (excavatum, asymmetric)          3/4 (75%)         18
  Spinal deformities                                                          NR                                                           No                                                                 Yes (mild to moderate scoliosis)                                No                                                No                                                                        Yes (mild lumbar scoliosis)                        Yes (scoliosis, thoracic kyphoscoliosis)   Yes (scoliosis)                      4/7 (57%)         22
  Finger shape characteristics                                                Yes (long, tapering)                                         Yes (long, slender, tapering)                                      Yes (long, slender, tapering)                                   Yes (cylingdrical)                                Yes (long, slender)                                                       Yes (long, slender)                                Yes (long, slender)                        Yes (long, slender)                  8/8 (100%)        35
  Progressive foot deformities                                                NR                                                           Yes (short, broad feet with short toes)                            NR                                                              Yes (wide feet with clawed toes)                  Yes                                                                       Yes (cavus)                                        Yes (uni. planus)                          Yes (hallux valgus, planus, cavus)   6/6 (100%)        26
  Marfanoid habitus/slender build                                             NR                                                           NR                                                                 NR                                                              No                                                NR                                                                        No                                                 Yes                                        Yes                                  2/4 (50%)         13
  Joint hypermobility                                                         Yes                                                          Yes[^b^](#mgg31197-note-0004){ref-type="fn"}                       Yes[^b^](#mgg31197-note-0004){ref-type="fn"}                    No                                                NR                                                                        Yes                                                No                                         No                                   4/7 (57%)          
  Osteoporosis                                                                NR                                                           NR                                                                 NR                                                              NR                                                NR                                                                        NR                                                 Yes                                        NR                                   1/1 (100%)         
  Others                                                                                                                                   Joint pain                                                                                                                         Chronic pain, brachydactyly, Madelung deformity   Torticollis                                                                                                                  Joint pain                                 Fractures                                               
  Skin                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
  Hyperextensibility                                                          NR                                                           Yes                                                                Yes                                                             No[^c^](#mgg31197-note-0005){ref-type="fn"}       No                                                                        Yes                                                No                                         No                                   3/7 (43%)         24
  Bruisability                                                                NR                                                           Yes                                                                Yes                                                             NR                                                Yes                                                                       No                                                 No                                         Yes                                  4/6 (67%)         21
  Fragility                                                                   NR                                                           Yes                                                                Yes                                                             No                                                No                                                                        No                                                 No                                         No                                   2/7 (29%)         21
  Atrophic scars                                                              Yes                                                          NR                                                                 NR                                                              NR                                                No                                                                        No                                                 No                                         Yes                                  2/5 (40%)          
  Hyperalgesia to pressure                                                    NR                                                           NR                                                                 NR                                                              NR                                                NR                                                                        NR                                                 NR                                         NR                                   0/0 (0%)          8
  Fine or acrogeria‐like palmar creases                                       Yes                                                          Yes                                                                Yes                                                             Yes                                               No                                                                        Yes                                                Yes                                        Yes                                  7/8 (88%)         28
  Recurrent subcutaneous infections                                           NR                                                           NR                                                                 NR                                                              NR                                                NR                                                                        No                                                 No                                         No                                   0/3 (0%)          8
  Fistula formation                                                           NR                                                           NR                                                                 NR                                                              NR                                                NR                                                                        No                                                 No                                         No                                   0/3 (0%)           
  Delayed wound healing                                                       Yes                                                          NR                                                                 NR                                                              NR                                                NR                                                                        Yes                                                No                                         No                                   2/4 (50%)          
  Umbilical hernia                                                            NR                                                           NR                                                                 NR                                                              NR                                                NR                                                                        Yes                                                No                                         No                                   1/3 (33%)          
  Others                                                                                                                                   Transparent, thin                                                  Transparent, thin                                               Piezogenic pedal papules                                                                                                                                                                                                                                                          
  Cardiovascular                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
  Congenital heart defects                                                    Yes (PFO)                                                    NR                                                                 No                                                              No                                                Yes (ASD)                                                                 Yes (ASD, PDA)                                     No                                         NR                                   3/6 (50%)         6
  Valve abnormalities                                                         No                                                           Yes (MVP, myxomatous valve with ruptureed chordae, severe MR)      No                                                              No                                                NR                                                                        No                                                 No                                         NR                                   1/6 (17%)         7
  Enlargement of ascending aorta                                              No                                                           No                                                                 No                                                              No                                                NR                                                                        No                                                 No                                         NR                                   0/6 (0%)          2
  Large subcutaneous hematoma                                                 NR                                                           Yes                                                                Yes                                                             NR                                                No                                                                        Yes (elbow, arm, forehead, knee, gluteal region)   NR                                         Yes (calf)                           4/5 (80%)         20
  Respiratory                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
  Pneumothorax/Hemopneumothorax                                               NR                                                           NR                                                                 NR                                                              No                                                No                                                                        No                                                 No                                         No                                   0/5 (0%)          3
  Gastrointestinal                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
  Constipation                                                                NR                                                           NR                                                                 NR                                                              No                                                No                                                                        Yes                                                No                                         No                                   1/5 (20%)         9
  Diverticula (e.g. perforation, infection)                                   NR                                                           NR                                                                 NR                                                              No                                                No                                                                        No                                                 No                                         No                                   0/5 (0%)          4
  Others                                                                                                                                                                                                      Eventration after gallbladder surgery                                                                                                                                                                                                                                                                                                             
  Urological                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
  Nephrolithiasis or cystolithiasis                                           NR                                                           NR                                                                 NR                                                              NR                                                NR                                                                        No                                                 NR                                         NR                                   0/1 (0%)          7
  Hydronephrosis                                                              NR                                                           NR                                                                 NR                                                              No                                                NR                                                                        Yes (bil)                                          NR                                         NR                                   1/2 (50%)         10
  Bladder dysfunction                                                         NR                                                           Yes (prolapse after two deliveries)                                NR                                                              NR                                                NR                                                                        No                                                 NR                                         NR                                   1/2 (50%)         2
  Recurrent urinary tract infection                                           NR                                                           NR                                                                 NR                                                              NR                                                NR                                                                        No                                                 NR                                         NR                                   0/1 (0%)          3
  Inguinal hernia                                                             Yes (lt)                                                     NR                                                                 Yes                                                             Yes (bil)                                         NR                                                                        Yes (lt)                                           No                                         No                                   4/6 (67%)         2
  Cryptorchidism in male                                                      NR                                                                                                                                                                                              Yes                                               No                                                                        Yes (bil)                                                                                     No                                   2/4 (50%)         17
  Ophthalmological                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
  Strabismus                                                                  NR                                                           No                                                                 No                                                              No                                                Yes                                                                       Yes (esotropia)                                    No                                         No                                   2/7 (29%)         14
  Glaucoma or elevated intraocular pressure                                   NR                                                           No                                                                 No                                                              No                                                No                                                                        No                                                 No                                         No                                   0/7 (0%)          8
  Refractive error                                                            NR                                                           No                                                                 No                                                              Yes (my)                                          No                                                                        Yes (my)                                           Yes (as)                                   Yes (my)                             4/7 (57%)         16 (hy 4, my 12, as 5)
  Retinal detachment                                                          NR                                                           No                                                                 No                                                              NR                                                NR                                                                        No                                                 No                                         No                                   0/5 (0%)          6
  Otological                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
  Hearing impairment                                                          NR                                                           NR                                                                 NR                                                              NR                                                NR                                                                        Yes (mild, uni, SNHL for high‐pitched sound)       No                                         No                                   1/3 (33%)         10
  Sexual development‐related                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
  Hypogonadism                                                                NR                                                           NR                                                                 NR                                                              NR                                                NR                                                                        No                                                 NR                                         No                                   0/2 (0%)           
  Others                                                                                                                                   Uterine prolapse after two deliveries                                                                                                                                                                                                                                                                                                                                                                                
  Central nervous system                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
  Ventricular abnormalities (enlargement, asymmetry)                          No                                                           NR                                                                 NR                                                              NR                                                No                                                                        No                                                 NR                                         NR                                   0/3 (0%)          8
  Hypoplasia of septum pellucidum                                             No                                                           NR                                                                 NR                                                              NR                                                No                                                                        No                                                 NR                                         NR                                   0/3 (0%)           
  Dandy‐Walker variant                                                        No                                                           NR                                                                 NR                                                              NR                                                No                                                                        No                                                 NR                                         NR                                   0/3 (0%)           
  Muscular system                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
  Hypotonia                                                                   NR                                                           Yes                                                                Yes                                                             NR                                                NR                                                                        Yes                                                NR                                         NR                                   3/3 (100%)        14
  Muscle weakness                                                             Yes                                                          Yes                                                                NR                                                              NR                                                NR                                                                        Yes                                                No                                         No                                   3/5 (60%)          
  Development                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
  Motor developmental delay                                                   Yes                                                          NR                                                                 NR                                                              NR                                                Yes                                                                       Yes                                                No                                         NR                                   3/4 (75%)         23
  Intellectual disabilities                                                   No                                                           NR                                                                 NR                                                              No                                                NR                                                                        No                                                 No                                         Yes                                  1/5 (20%)         4

Abbreviations: as, astigmatism; ASD, atrial septal defect; bil, bilateral; F, female; hy, hyperopia; lt, left; M, male; MR, mitral valve regurgitation; MVP, mitral valve prolapse; my, myopia; No, absent; NR, not recorded; PDA, patent ductus arteriosus; PFO, persistent foramen ovale; SNHL, sensorineural hearing loss; uni, unilateral; Yes, present.

Judged from images in the relevant report.

In younger ages but not in adulthood.

Only at the elbows.

John Wiley & Sons, Ltd

Frequent (affecting at least three patients) craniofacial and skeletal features in mcEDS‐*DSE* are shown in Table [1](#mgg31197-tbl-0001){ref-type="table"}. Two reported patients (Schirwani et al., [2019](#mgg31197-bib-0014){ref-type="ref"}; Syx et al., [2015](#mgg31197-bib-0015){ref-type="ref"}) and patient 2 in the present report had joint pain. Frequent skin, vascular, ocular, nervous, and muscle features are also shown in Table [1](#mgg31197-tbl-0001){ref-type="table"}. Even though the number of patients with mcEDS‐*DSE* is small and an accurate frequency of each feature in patients with mcEDS‐*CHST14* is unavailable, the general patterns of symptoms seem to be similar between the two subtypes. However, several patients with mcEDS‐*CHST14* had life‐threatening complications (e.g., infectious endocarditis, Kono et al., [2016](#mgg31197-bib-0005){ref-type="ref"}; Kosho, Miyake, & Hatamochi, [2010](#mgg31197-bib-0006){ref-type="ref"}, fulminant gastric ulcer, Kosho et al., [2010](#mgg31197-bib-0006){ref-type="ref"}; diverticular perforation, Kosho et al., [2010](#mgg31197-bib-0006){ref-type="ref"}; Mochida, Amano, & Miyake, [2016](#mgg31197-bib-0011){ref-type="ref"}), and five patients died (Dündar, Kurtoglu, & Elmas, [2001](#mgg31197-bib-0002){ref-type="ref"}; Janecke, Li, & Boehm, [2016](#mgg31197-bib-0004){ref-type="ref"}). No such serious complication has yet been observed in patients with mcEDS‐*DSE*. Syx et al. ([2015](#mgg31197-bib-0015){ref-type="ref"}) hypothesized that the residual availability of some DS structures, including iduronic acid‐containing disaccharide units, might contribute to an attenuated phenotype.

In conclusion, mcEDS‐*DSE* constitutes a multisystem disorder with congenital and progressive features, as well as the depletion of DS, similar to mcEDS‐*CHST14*. However, symptoms tend to be milder in patients with mcEDS‐*DSE*.
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